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Sufficient skin dose needs to be delivered by a radiotherapy chest wall treatment regimen to ensure
the probability of a near surface tumor recurrence is minimized. To simulate a chest wall treatment
a hemicylindrical solid water phantom of 7.5 cm radius was irradiated with 6 MV x-rays using
20320 cm2 and 10320 cm2 fields at 100 cm source surface distance~SSD! to the base of the
phantom. A surface dose profile was obtained from 0 to 180°, in 10° increments around the
circumference of the phantom. Dosimetry results obtained from radiochromic film~effective depth
of 0.17 mm! were used in the investigation, the superficial doses were found to be 28%~of Dmax)
at the 0° beam entry position and 58% at the 90° oblique beam position. Superficial dose results
were also obtained using extra thin thermoluminescent dosimeters~TLD! ~effective depth 0.14 mm!
of 30% at 0°, 57% at 90°, and a metal oxide semiconductor field effect transistor~MOSFET!
detector~effective depth 0.5 mm! of 43% at 0°, 62% at 90°. Because the differences in measured
superficial doses were significant and beyond those related to experimental error, these differences
are assumed to be mostly attributable to the effective depth of measurement of each detector. We
numerically simulated a bolus on/bolus off technique and found we could increase the coverage to
the skin. Using an alternate ‘‘bolus on,’’ ‘‘bolus off’’ regimen, the skin would receive 36.8 Gy at
0° incidence and 46.4 Gy at 90° incidence for a prescribed midpoint dose of 50 Gy. From this work
it is evident that, as the circumference of the phantom is traversed the SSD increases and hence
there is an inverse square fluence fall-off, this is more than offset by the increase in skin dose due
to surface curvature to a plateau at about 90°. Beyond this angle it is assumed that beam attenuation
through the phantom and inverse square fall-off is causing the surface dose to reduce. ©2000
American Association of Physicists in Medicine.@S0094-2405~00!00107-3#
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I. INTRODUCTION
Skin dose assessment to the chest wall~breast! region is
important to ensure that sufficient dose is given to structures
at risk from near surface recurrence1 ~ .g., scars, dermal lym-
phatics! while not exceeding the tolerance level required for
acceptable skin cosmesis.2 The superficial layers of interest
include the dermal lymphatics which extend to about 1 mm
depth and the basal cell layer at about 70mm.3
Patients undergoing radiotherapy treatment receive an in-
herent skin sparing effect due to the range of electrons set in
motion from megavoltage x-ray beam interactions.4,5 An ad-
ditional, skin dose component is due to electron contamina-
tion, the magnitude of which depends on parameters such as
beam modifiers, field size, and air gap.5–10 The dependence
of surface dose on angle of incidence has been measured in
slab phantoms11–14 and in vivo at a few discrete points in-
cluding the entry and exit position.6 The effect of a curved
contour with overshooting beams in a configuration resem-
bling two chest wall tangent fields is the subject of this re-
port. The study also outlines the impact of adding 1 cm of
bolus.
II. MATERIALS AND METHODS
To simulate a chest wall~post mastectomy! breast treat-
ment a hemicylindrical solid water phantom,15 of 7.5 cm
radius was irradiated with 6 MV x-rays from a Varian 2100C
at 100 cm source surface distance~SSD! ~see Fig. 1!. Three
radiation detector types were used in the investigation, radio-
chromic film ~Gafchromic MD-55-2/Lot No. 97011! ther-
moluminescent dosimeters~TLDs! ~solon/Harshaw, USA! of
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three different nominal thicknesses, and a MOSFET@Radfet
~Courtesy of Rem, Oxford, UK!#. Radiation measurements
were undertaken for all detectors using a 20320 cm2 field at
nominal SSD, the point where the hemicylinder starts. This
field size ensured detector measurements could be normal-
ized to dmax in a central axis beam position. Tangent fields
are generally rectangular to ensure less lung dose, therefore a
more clinically typical field of 10320 cm2 half-jaw was also
tested using the radiochromic film detector.
A. Radiochromic film
For the 20320 cm2 field the hemicylindrical solid water
phantom was marked from 0°~i.e., beam entry! to 180°~i.e.,
beam exit! in 10° increments. A strip of radiochromic film
with the dimensions of 1 cm316 cm was placed around the
arc on the surface of the hemicylinder. Measurements were
made at the central axis from the entrance to the exit beam
location. Because the 0° and 180° positions for the 10
320 cm2 field were in the penumbra, only measurements
from 10° to 170° were undertaken. The optical density of the
irradiated film was read using a 660 nm modified
densitometer.16 These readings were then converted to dose
using a calibration curve. This was performed by irradiating
films from the same batch to known doses atdmax in a solid
water ~Radiation Measurements Inc. RMI, USA! phantom.
Doses of between 0 Gy and 20 Gy were delivered in 2 Gy
increments. A calibration curve was then created using a
third order polynomial fit to the data.17 The radiochromic
film was determined as having an effective measurement
depth of 0.1760.03 mm. This thickness was determined by
comparison to the Attix chamber. Note the thickness of the
outer ~protective! layer of the film is about 0.012 g/cm2 ac-
cording to the manufacturer.18–26
B. Thermoluminescent dosimeters
Three different thicknesses of TLD chips were used.
Lithium fluoride ~LiF! crystals doped with magnesium and
titanium were used with nominal thicknesses@0.14 mm~ex-
tra thin!, 0.39 mm~thin!, and 0.89 mm~normal!#. The details
of how these nominal thicknesses were determined are out-
lined in a previous paper by Kronet al.14 The TLD’s from
Harshaw Chemicals~Solon/Harshaw, USA! were used. Thin
and normal chips were made from LiF with the natural mix-
ture of lithium ~TLD 100!. The extra thin TLDs were how-
ever only available as TLD 700 material containing the iso-
tope 7Li enriched. This reduces the TLD response to
neutrons but does not alter the TLD properties in x-ray fields.
The chips were read out in a NE Rialto TLD reader in a
two step read out cycle. The readout temperature was 300 °C.
All TLD chips were annealed in a dedicated annealing oven
at 400 °C for 1 hour followed by fan forced cool down to
100 °C which was held for 2 hours. For each TLD, readings
were normalized to the relative response of that dosimeter at
100 cGy. Each chip was characterized by an individual sen-
sitivity value which was obtained as outlined elsewhere.27
C. MOSFET dosimeter
A MOSFET was also used in the investigation. The de-
tector consisted of a source, drain and gate placed on a sub-
strate. The dimensions of the active detector are 0.55 mm
31.10 mm attached to the tip of an alumina substrate with
epoxy. Other details of the construction of the detector can
be found in the paper published by Gladstoneet al.28 Many
MOSFET devices have leads underneath with a metal casing
which would have been difficult to mount for these experi-
ments. By placing the detector on the surface of the hemicy-
lindrical phantom in 10° increments. All the data obtained
from each dosimeter was converted to show surface dose
profiles. The MOSFET detector was estimated to have an
effective measurement depth of 0.5 mm by scaling the 0.3
mm thickness of the epoxy coating with a density of 1.5.29–31
All MOSFET detector response values were normalized to a
standard dose of~20 cGy! at dmax for a 10310 cm
2 square
field at 100 cm SSD. Directional dependence of this device
was tested by placing it at 10 cm depth in a cylindrical phan-
tom. In equilibrium conditions at 7.5 cm depth variations in
dose recorded from angle 0° to 60° was63%.
The experiment was repeated using a 1 cmbolus ~Med-
Tec, USA! with radiochromic film measurement only. By
combining the results and normalizing to a prescribed mid-
point dose of 50 Gy~i.e., from two tangent fields!, using an
alternate ‘‘bolus on,’’ ‘bolus off’ regimen, patient skin dose
was calculated from the measurements.
III. RESULTS
The results of measurements, taken at 10° increments, us-
ing radiochromic film, MOSFET detectors, extra thin, thin
and normal TLD are presented in Fig. 2. Uncertainties are
expressed as6 two standard deviations and they are as fol-
lows: radiochromic film63%, MOSFET63%, extra thin
TLD 63%, and normal TLD62%.13,14,30Note the charac-
teristic shape of the curve indicated how the near superficial
dose increases with the effective depth of measurement of
the detectors. Note that entrance percentage superficial dose
~%Dose! was 30% and exit was 39% for the extra thin TLDs.
For the thin TLDs the results were 36% and 47%, respec-
FIG. 1. The hemicylindrical chest wall phantom used to simulate a tangential
breast treatment. A 20320 cm2 x-ray beam with 2.5 cm overshoot was set
incident at 100 cm SSD, for some of the radiochromic film readings 1 cm of
bolus was added.
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tively. For the normal thickness TLD’s the readings were
49% and 50%. The subsequent results were 28% and 47%
for the radiochromic film, and 43%, 46% for the MOSFET,
respectively.
At 90°, the peak of the percentage superficial dose for all
three dosimeters were 57%~extra thin TLD!, 73% ~thin
TLD!, 75% ~normal TLD!, 58%~Radiochromic film!, and
62% ~MOSFET!.
Figure 3 shows the incident percentage dose measured
using radiochromic film for 20320 cm2 and 10320 cm2 tan-
gent fields, with and without 1 cm of bolus present. The
smaller field size shows less incident surface dose particu-
larly at the angles 0° to 60° without bolus. Adding bolus
causes a large increase~350%! in dose at shallow incident
angles~,60°! but at steep incident angles~.140°! the inci-
dent dose is only increased by 10% with the bolus. The in-
crease in dose on the entrance side is due to the increase in
buildup material. The increase in dose on the exit side is due
to an increase in back scatter material. The data presented in
Fig. 3 can be used to predict the surface dose for a parallel
opposed treatment where 50 Gy is delivered to the midline of
the breast. Figure 4 presents this data with and without bolus
as well as with bolus for half the fractions.
IV. DISCUSSION AND CONCLUSION
In the interests of normalizing dose to a central axis ref-
erence position a 20320 cm2 field was used. It is acknowl-
edged that a half-jaw 10320 cm2 field is more clinically re-
alistic. The differences showed in Fig. 4 for measurements
without bolus~e.g., between 26% and 32% at 10°! indicate
that the main difference at shallow angle of incidence is due
to less electron contamination for the smaller rectangular
field size. To confirm this the electron contamination of a
10320 cm2 and 20320 cm2 was measured using an Attix
model 449 parallel plate ionization chamber and a 6%~i.e.,
as percentage ofDmax) difference was found.
In clinical setup it is common for part of one edge of the
beam to pass through lung. In general the lack of attenuation
in a low density medium would lead to an increase in exit
dose.32,33 However disequilibrium in these regions can lead
to penumbral flaring and a deficit of dose in lung which then
has a secondary buildup.34 This phantom does not attempt to
measure dose enhancement or attenuation when lung is in-
volved.
When clinicians are concerned about a near surface recur-
rence they may use bolus continuously or on alternate days
of treatment. The minimum dose for each scenario was at the
beam entry position angle~i.e., 0°!. For a 50 Gy prescribed
midline dose the dose at this position would be 23.6 Gy
without bolus, 50 Gy with bolus, and 36.8 Gy with bolus
applied for half the fractions. The maximum dose for each
scenario was at the most oblique beam angle~i.e., 90°!. The
dose at this position was 36.6 Gy without bolus, 56.2 Gy
with bolus, and 46.4 Gy with bolus applied for half the frac-
tions.
Note that the use of a thicker bolus placed on alternate
days probably gives a more homogeneous final dose distri-
FIG. 2. Percentage near surface dose obtained using various detectors in-
cluding radiochromic~Gafchromic MD 55-2! film, TLDs ~extra thin, thin
and normal!, and a MOSFET detector. Normalized to incident dose atdmax
for each detector.
FIG. 3. Percentage dose at the phantom surface for an x-ray field with and
without 1 cm of bolus for 20320 cm2 and 10320 cm2 field size as mea-
sured using radiochromic film. Normalized to incident dose atdmax.
FIG. 4. Combined surface dose vs angle on a hemicylindrical surface with
bolus on for all fractions, bolus off for all fractions, and bolus on for half the
fractions. All data normalized to 50 Gy midline dose.
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bution because the bolus is close to thedmax thickness where
dose gradients are reduced. There is a potential radiobiologi-
cal difference between the dose delivered in this manner on
alternate days vs the same dose per fraction each day. How-
ever using the linear quadratic model and typical
parameters,5,35,36 this difference is relatively small. For ex-
ample at 0° the biological effective dose~BED! for tumor
control was 42.9Gy10 for the uneven dose fraction delivery
vs 42.2Gy10 if the dose were delivered using even fractions.
For late effects the difference is only a little more. The BED
is 57.1 Gy3 ~bolus on/off! vs 54.9 Gy3 ~half-bolus!. If prolif-
eration is considered the BED changes but the offset between
each regimen does not.
Radiochromic film is potentially a useful tool as an inte-
grative skin dosimeter in radiotherapy. It can measure a sur-
face dose profile at a physical effective depth of 0.17 mm,
hence superficial dose can be determined. The film is light
weight and can be cut to any size or shape to be used clini-
cally. Radiochromic film can be used in the dose range from
10 to 100 Gy. The film can be used a multiple number of
times until a total dose of 100 Gy is accumulated. Its lack of
sensitivity is in-turn a potential disadvantage for use on pa-
tients. Unlike radiochromic film, TLD detectors can only be
used to check discrete points,in vivo to determine the dose
received. However at this time TLDs still maintain a more
clinically useful sensitivity range than radiochromic film.
MOSFET detectors provide instant read out and can store
previous readings. The construction of the detector is com-
pact, of minimal weight, and can be used on any surface. The
detector itself does not involve a connection to a high volt-
age terminal. The spatial resolution~1 mm! is extremely
good for these detectors. However as previously discussed in
the methods section there is some directional sensitivity
probably due to the packaging at very oblique angles.31
The investigation has outlined different detectors with dif-
ferent responses to surface dose measurement. These differ-
ences are likely to be mainly due to the effective depth of
measurement for each detector. Radiochromic film proved to
be adequate for this work, but its low sensitivity precludes its
use as anin vivo dosimeter for single fraction dose monitor-
ing. It would be clinically more useful if a more radiation
sensitive type was available.37 TLD still provides a good
clinical skin dose measurement despite the somewhat high
work input required to anneal and calibrate these detectors.
MOSFET dosimeters are very dose sensitive~i. ., 10 cGy!
and thus could be placedin vivo for the first part of a dose
fraction to assess skin dose, MOSFETs do however currently
have a finite lifetime which is proportional to the bias volt-
age applied. The continued use of these detectors probably
depends somewhat on the low cost of providing replacement
detectors.
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